Key facts
- 9amHealth’s last known valuation is $155.0M (Mar 2026).
- It has raised $64.1M across 4 recorded rounds; the latest was Early Stage VC ($25.7M) in Mar 2026.
- Notable investors include Founders Fund, Speedinvest, Human Capital, Calm/Storm Ventures, iSeed Ventures — 13 tracked in total.
- 9amHealth has filed 4 Form Ds with the SEC since 2021, most recently Feb 2024 ($9.6M sold to 5 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for 9amHealth
Funding rounds
4 roundsAbout 9amHealth
Provider of digital healthcare services intended to offer integrated care for cardiometabolic conditions. The company offers personalized care plans, access to medical specialists, prescription management, at-home testing, connected health monitoring tools, nutrition and lifestyle guidance, and ongoing clinical support, enabling individuals and healthcare organizations to manage weight, diabetes, and heart health through continuous, coordinated care and improved long-term health outcomes.
- Sector
- Healthcare
- HQ
- Encinitas, CA, United States
- Founded
- 2021
- Employees
- 46
- Website
- join9am.com/
- Ownership
- Privately Held (backing)
9amHealth doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in 9amHealth shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on 9amHealth in its N-PORT filings yet. We sweep new filings monthly.